Extension Agreement between BioRidge Pharma, LLC and Hemispherx Biopharma, Inc. (August 2015)

Contract Categories: Business Finance › Modification Agreements
Summary

BioRidge Pharma, LLC and Hemispherx Biopharma, Inc. have agreed to extend their existing contracts, originally signed in August 2011 and previously extended in 2012, 2013, and 2014. The extension continues all current terms and conditions through August 14, 2017. Both parties have acknowledged and accepted the extension by signature. No other changes to the agreement are specified.

Read More Arrow
EX-10.2 3 heb-20150630xex102bioridge.htm EXHIBIT 10.2 BIORIDGE HEB-2015.06.30-EX 10.2 (BioRidge)




BIORIDGE
PHARMA
Specially Distributors of Biotech Products

July 29, 2015

Dr. William A. Carter Chairman and CEO
Hemispherx Biopharma, Inc. JFK Boulevard
Suite 500
Philadelphia, Pa 19103


Re: Agreement Between BioRidge Pharma and Hemispherx Biopharma, Inc.

Dear Dr. Carter,
BioRidge Pharma would like to request an extension to the above mentioned contracts, initially signed on August 15, 2011 and extended in 2012, 2013 and 2014 subject to the same terms and conditions currently in place.

Please sign this acceptance letter as acknowledgment of the extension through August 14,
2017 and return to my attention via fax or e-mail. I can be reached at ###-###-#### if you
have any questions or concerns.

Regards,

/S/: Robert Anderson
Robert Anderson, CFO
Bio Ridge Pharma, LLC Phone: 973 ###-###-#### Fax: 973 ###-###-####
                                                                                              /S/: William A. Carter    _______________                                                                                                                                                                                                                                                                                                                                                                                                                                                 (signature)
                                                                                                                                                                                                                                                                                            
William A. Carter____________________
(print name)

CEO and Chairman___________________
(Title)

_7/31/15____________________________
(Date)